180 related articles for article (PubMed ID: 19424974)
41. Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression.
Yang G; Timme TL; Frolov A; Wheeler TM; Thompson TC
Cancer; 2005 Mar; 103(6):1186-94. PubMed ID: 15712208
[TBL] [Abstract][Full Text] [Related]
42. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy.
Buffa FM; Bentzen SM; Daley FM; Dische S; Saunders MI; Richman PI; Wilson GD
Clin Cancer Res; 2004 Jun; 10(11):3745-54. PubMed ID: 15173081
[TBL] [Abstract][Full Text] [Related]
43. Clinical and pathologic factors of prognostic significance in penile squamous cell carcinoma in a North American population.
Bethune G; Campbell J; Rocker A; Bell D; Rendon R; Merrimen J
Urology; 2012 May; 79(5):1092-7. PubMed ID: 22386252
[TBL] [Abstract][Full Text] [Related]
44. Grade as a prognostic factor in oral squamous cell carcinoma: a population-based analysis of the data.
Thomas B; Stedman M; Davies L
Laryngoscope; 2014 Mar; 124(3):688-94. PubMed ID: 23945976
[TBL] [Abstract][Full Text] [Related]
45. Correlation of p53 and Ki-67 (MIB-1) expressions with clinicopathological features and prognosis of early stage cervical squamous cell carcinomas.
Hanprasertpong J; Tungsinmunkong K; Chichareon S; Wootipoom V; Geater A; Buhachat R; Boonyapipat S
J Obstet Gynaecol Res; 2010 Jun; 36(3):572-80. PubMed ID: 20598040
[TBL] [Abstract][Full Text] [Related]
46. Analysis of p16(INK4A) expression of oral squamous cell carcinomas in Taiwan: prognostic correlation without relevance to betel quid consumption.
Chen YW; Kao SY; Yang MH
J Surg Oncol; 2012 Aug; 106(2):149-54. PubMed ID: 22354873
[TBL] [Abstract][Full Text] [Related]
47. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX
J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003
[TBL] [Abstract][Full Text] [Related]
48. Clinicopathological significance of carbonic anhydrase 9, glucose transporter-1, Ki-67 and p53 expression in oral squamous cell carcinoma.
Kondo Y; Yoshikawa K; Omura Y; Shinohara A; Kazaoka Y; Sano J; Mizuno Y; Yokoi T; Yamada S
Oncol Rep; 2011 May; 25(5):1227-33. PubMed ID: 21399882
[TBL] [Abstract][Full Text] [Related]
49. Serum decoy receptor 3 level: a predictive marker for nodal metastasis and survival among oral cavity cancer patients.
Tu HF; Liu CJ; Liu SY; Chen YP; Yu EH; Lin SC; Chang KW
Head Neck; 2011 Mar; 33(3):396-402. PubMed ID: 20645287
[TBL] [Abstract][Full Text] [Related]
50. [The ASA-score as a comorbidity index in patients with cancer of the oral cavity and oropharynx].
Riechelmann H; Neagos A; Netzer-Yilmaz U; Gronau S; Scheithauer M; Rockemann MG
Laryngorhinootologie; 2006 Feb; 85(2):99-104. PubMed ID: 16498538
[TBL] [Abstract][Full Text] [Related]
51. Bcl-xL protein: predictor of complete tumor response in patients with oral cancer treated with curative radiotherapy.
Mallick S; Agarwal J; Kannan S; Pawar S; Kane S; Teni T
Head Neck; 2013 Oct; 35(10):1448-53. PubMed ID: 22987535
[TBL] [Abstract][Full Text] [Related]
52. Analysis of Ki-67 expression in oral squamous cell carcinoma: why Ki-67 is not a prognostic indicator.
Gonzalez-Moles MA; Ruiz-Avila I; Gil-Montoya JA; Esteban F; Bravo M
Oral Oncol; 2010 Jul; 46(7):525-30. PubMed ID: 20400362
[TBL] [Abstract][Full Text] [Related]
53. Multiple genetic copy number alterations in oral squamous cell carcinoma: study of MYC, TP53, CCDN1, EGFR and ERBB2 status in primary and metastatic tumours.
Martín-Ezquerra G; Salgado R; Toll A; Gilaberte M; Baró T; Alameda Quitllet F; Yébenes M; Solé F; Garcia-Muret M; Espinet B; Pujol RM
Br J Dermatol; 2010 Nov; 163(5):1028-35. PubMed ID: 20662834
[TBL] [Abstract][Full Text] [Related]
54. Identification of site-specific prognostic biomarkers in patients with oral squamous cell carcinoma.
Trivedi TI; Tankshali RA; Goswami JV; Shukla SN; Shah PM; Shah NG
Neoplasma; 2011; 58(3):217-26. PubMed ID: 21391738
[TBL] [Abstract][Full Text] [Related]
55. EGFR and Ki-67 expression in oral squamous cell carcinoma using tissue microarray technology.
Monteiro LS; Diniz-Freitas M; Garcia-Caballero T; Forteza J; Fraga M
J Oral Pathol Med; 2010 Aug; 39(7):571-8. PubMed ID: 20202087
[TBL] [Abstract][Full Text] [Related]
56. Prognostic significance of nuclear pSTAT3 in oral cancer.
Macha MA; Matta A; Kaur J; Chauhan SS; Thakar A; Shukla NK; Gupta SD; Ralhan R
Head Neck; 2011 Apr; 33(4):482-9. PubMed ID: 20652980
[TBL] [Abstract][Full Text] [Related]
57. Four-protein signature accurately predicts lymph node metastasis and survival in oral squamous cell carcinoma.
Zanaruddin SN; Saleh A; Yang YH; Hamid S; Mustafa WM; Khairul Bariah AA; Zain RB; Lau SH; Cheong SC
Hum Pathol; 2013 Mar; 44(3):417-26. PubMed ID: 23026198
[TBL] [Abstract][Full Text] [Related]
58. Prognostics of Cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma.
Khan H; Gupta S; Husain N; Misra S; Singh N; Negi MP
J Cancer Res Ther; 2014; 10(2):258-64. PubMed ID: 25022375
[TBL] [Abstract][Full Text] [Related]
59. Prognostic value of the sixth edition of the UICC's TNM classification and stage grouping for oral cancer.
Kreppel M; Eich HT; Kübler A; Zöller JE; Scheer M
J Surg Oncol; 2010 Oct; 102(5):443-9. PubMed ID: 20872947
[TBL] [Abstract][Full Text] [Related]
60. Significance of Ki-67 and p53 immunoexpression in the differential diagnosis of oral necrotizing sialometaplasia and squamous cell carcinoma.
Dadfarnia T; Mohammed BS; Eltorky MA
Ann Diagn Pathol; 2012 Jun; 16(3):171-6. PubMed ID: 22197541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
